Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Liver Diseases Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03365635
What this trial is testing

Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C

Who this might be right for
Hepatitis CHemodialysisNosocomial Infection
University of Pennsylvania 6
Early research (Phase 1)WithdrawnNCT01851460
What this trial is testing

Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Diseases (CGD) and Liver Lesions
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT01263860
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-6 Patients

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 242
Post-approval studies (Phase 4)Study completedNCT02214420
What this trial is testing

SMV + SOF With/Without RBV for IFN-II Patients With CHC

Who this might be right for
Hepatitis C
SC Liver Research Consortium, LLC 24
Not applicableStudy completedNCT02581189
What this trial is testing

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

Who this might be right for
Chronic Hepatitis C
AbbVie 565
Large-scale testing (Phase 3)Ended earlyNCT00412750
What this trial is testing

Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B
Novartis 159
Not applicableStudy completedNCT04439084
What this trial is testing

COVID-19 in Patients With Chronic Liver Diseases

Who this might be right for
COVID-19Chronic Liver Disease
Stanford University 1,025
Not applicableStudy completedNCT03155906
What this trial is testing

Integrated Treatment of Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, ChronicOpioid Dependence, on Agonist Therapy
Haukeland University Hospital 298
Testing effectiveness (Phase 2)Study completedNCT01687257
What this trial is testing

Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation

Who this might be right for
Hepatitis CCirrhosisPortal Hypertension+1 more
Gilead Sciences 50
Post-approval studies (Phase 4)Study completedNCT00926614
What this trial is testing

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Who this might be right for
Hepatitis c
Brooke Army Medical Center 20
Not applicableStudy completedNCT01237574
What this trial is testing

Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease

Who this might be right for
Liver Diseases, AlcoholicMetabolic Diseases
University Hospital, Bordeaux 527
Testing effectiveness (Phase 2)Study completedNCT01220947
What this trial is testing

Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 421
Post-approval studies (Phase 4)Study completedNCT02791269
What this trial is testing

Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 24
Large-scale testing (Phase 3)Study completedNCT00039962
What this trial is testing

Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Who this might be right for
Hepatitis CHepatitis C, Chronic
SciClone Pharmaceuticals 500
Large-scale testing (Phase 3)UnknownNCT02732405
What this trial is testing

Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis

Who this might be right for
Hepatitis CCompensated Cirrhosis
Istituto Clinico Humanitas 120
Not applicableLooking for participantsNCT03920618
What this trial is testing

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

Who this might be right for
Hepatitis BAcute-On-Chronic Liver Failure
Third Affiliated Hospital, Sun Yat-Sen University 150
Very early researchUnknownNCT05786859
What this trial is testing

The Efficacy and Safety of Rifaximin Treatment

Who this might be right for
Liver Failure, Acute on ChronicHepatic EncephalopathyHBV+3 more
Sun Yat-sen University 124
Testing effectiveness (Phase 2)Study completedNCT01183169
What this trial is testing

Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment

Who this might be right for
Hepatitis C
Debiopharm International SA 459
Not applicableStudy completedNCT01908660
What this trial is testing

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Who this might be right for
Human Immunodeficiency VirusHepatitis B, ChronicHepatitis C, Chronic
Valme University Hospital 192
Large-scale testing (Phase 3)Study completedNCT00158496
What this trial is testing

Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)

Who this might be right for
Chronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 100
Next Page